ARCHIVES

Proposed HHS Conflict of Interest Rules May Require More Disclosure by Researchers

This article is from The Cancer Letter archive.

Vol. 35 No. 19 | May 15, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

March 30, 2001

New Frederick Contract Drops Slightly From ‘75

July 11, 1975

Diet and Cancer Risk Explored In Studies Presented At AACR Annual Meeting

April 30, 2004

Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head.

September 9, 2005

ACS Medals Of Honor To Bonadonna, Hsu, Louis Sullivan

December 13, 1991

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001